These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2080295)

  • 21. Human HepG2 and rat Fao hepatic-derived cell lines show different responses to ciprofibrate, a peroxisome proliferator: analysis by flow cytometry.
    Passilly P; Jannin B; Hassell SJ; Latruffe N
    Exp Cell Res; 1996 Mar; 223(2):436-42. PubMed ID: 8601421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flow cytometry of DNA content and other indicators of proliferative activity.
    Shapiro HM
    Arch Pathol Lab Med; 1989 Jun; 113(6):591-7. PubMed ID: 2471483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flow cytometric determination of DNA content in malignant and benign bone tumours.
    Heliö H; Karaharju E; Nordling S
    Cytometry; 1985 Mar; 6(2):165-71. PubMed ID: 3979218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The application of flow cytometry for the quantification of the response of experimental tumors to irradiation.
    Beck HP; Brammer I; Zywietz F; Jung H
    Cytometry; 1981 Jul; 2(1):44-6. PubMed ID: 7273976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of laser flow cytometry in the study of fibrocystic mastopathy and breast cancer].
    Bogatyrev VN; Kupin VI; Polevaia EB
    Lab Delo; 1983; (9):16-8. PubMed ID: 6195424
    [No Abstract]   [Full Text] [Related]  

  • 26. DNA and RNA content analysis by flow cytometry in the pathobiologic assessment of bone tumors.
    el-Naggar AK; Hurr K; Tu ZN; Teague K; Raymond KA; Ayala AG; Murray J
    Cytometry; 1995 Mar; 19(3):256-62. PubMed ID: 7736870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor.
    Ruà S; Comino A; Fruttero A; Torchio P; Bouzari H; Taraglio S; Torchio B; Capussotti L
    Cancer; 1996 Sep; 78(6):1195-202. PubMed ID: 8826940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncology applications of flow cytometry.
    Huh YO; Huck L
    Clin Lab Sci; 1992; 5(1):25-7. PubMed ID: 10147718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
    Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
    Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake.
    Higashi K; Clavo AC; Wahl RL
    J Nucl Med; 1993 Mar; 34(3):414-9. PubMed ID: 8441032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relevance of cell kinetics for human cancer.
    Bush H
    Eur J Cancer (1965); 1980; Suppl 1():213-8. PubMed ID: 7318862
    [No Abstract]   [Full Text] [Related]  

  • 32. Cell proliferation and ploidy of human solid tumours: methodological experience with in vivo bromodeoxyuridine and DNA flow cytometry.
    Mazzini G; Danova M; Ferrari C; Giordano M; Dionigi P; Riccardi A
    Anal Cell Pathol; 1996 Mar; 10(2):101-13. PubMed ID: 8721953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three parameter flow cytometric analysis for simultaneous detection of cytokeratin, proliferation associated antigens and DNA content.
    Schutte B; Tinnemans MM; Pijpers GF; Lenders MH; Ramaekers FC
    Cytometry; 1995 Oct; 21(2):177-86. PubMed ID: 8582238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.
    Riccardi A; Danova M; Wilson G; Ucci G; Dörmer P; Mazzini G; Brugnatelli S; Girino M; McNally NJ; Ascari E
    Cancer Res; 1988 Nov; 48(21):6238-45. PubMed ID: 3167869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-cycle studies by multiparametric automatic scanning of topographically preserved cells in culture.
    Colomb E; Kopp F; Spyratos F; Martin PM
    Cytometry; 1989 May; 10(3):263-72. PubMed ID: 2714110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA content of T-cell lymphomas. A flow-cytometric analysis.
    Egerter DA; Said JW; Epling S; Lee S
    Am J Pathol; 1988 Feb; 130(2):326-34. PubMed ID: 3257649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor cell kinetics using two labels and flow cytometry.
    Ritter MA; Fowler JF; Kim YJ; Gilchrist KW; Morrissey LW; Kinsella TJ
    Cytometry; 1994 May; 16(1):49-58. PubMed ID: 8033734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attributes and applications of flow cytometry.
    Braylan RC
    Ann Clin Lab Sci; 1983; 13(5):379-84. PubMed ID: 6357046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell cycle kinetics of irradiated synchronous and asynchronous tumor cells with DNA distribution analysis and BrdUrd-Hoechst 33258-technique.
    Nüsse M
    Cytometry; 1981 Sep; 2(2):70-9. PubMed ID: 6169494
    [No Abstract]   [Full Text] [Related]  

  • 40. Proliferative cell indices measured by DNA flow cytometry in node-negative adenocarcinomas of breast: accuracy and significance in cytokeratin-stained archival specimens.
    Frei JV; Rizkalla K; Martinez VJ
    Mod Pathol; 1994 Dec; 7(9):925-9. PubMed ID: 7534400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.